282 related articles for article (PubMed ID: 17353273)
1. PIASy-mediated sumoylation of Yin Yang 1 depends on their interaction but not the RING finger.
Deng Z; Wan M; Sui G
Mol Cell Biol; 2007 May; 27(10):3780-92. PubMed ID: 17353273
[TBL] [Abstract][Full Text] [Related]
2. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
[TBL] [Abstract][Full Text] [Related]
3. Repression of E1AF transcriptional activity by sumoylation and PIASy.
Nishida T; Terashima M; Fukami K; Yamada Y
Biochem Biophys Res Commun; 2007 Aug; 360(1):226-32. PubMed ID: 17585876
[TBL] [Abstract][Full Text] [Related]
4. PIASy inhibits virus-induced and interferon-stimulated transcription through distinct mechanisms.
Kubota T; Matsuoka M; Xu S; Otsuki N; Takeda M; Kato A; Ozato K
J Biol Chem; 2011 Mar; 286(10):8165-8175. PubMed ID: 21199872
[TBL] [Abstract][Full Text] [Related]
5. PIASy-mediated repression of the androgen receptor is independent of sumoylation.
Gross M; Yang R; Top I; Gasper C; Shuai K
Oncogene; 2004 Apr; 23(17):3059-66. PubMed ID: 14981544
[TBL] [Abstract][Full Text] [Related]
6. Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.
Yueh A; Leung J; Bhattacharyya S; Perrone LA; de los Santos K; Pu SY; Goff SP
J Virol; 2006 Jan; 80(1):342-52. PubMed ID: 16352559
[TBL] [Abstract][Full Text] [Related]
7. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
[TBL] [Abstract][Full Text] [Related]
8. SUMO-1 modification of PIASy, an E3 ligase, is necessary for PIASy-dependent activation of Tcf-4.
Ihara M; Yamamoto H; Kikuchi A
Mol Cell Biol; 2005 May; 25(9):3506-18. PubMed ID: 15831457
[TBL] [Abstract][Full Text] [Related]
9. Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner.
Dahle Ø; Andersen TØ; Nordgård O; Matre V; Del Sal G; Gabrielsen OS
Eur J Biochem; 2003 Mar; 270(6):1338-48. PubMed ID: 12631292
[TBL] [Abstract][Full Text] [Related]
10. PIASy-mediated sumoylation of SREBP1c regulates hepatic lipid metabolism upon fasting signaling.
Lee GY; Jang H; Lee JH; Huh JY; Choi S; Chung J; Kim JB
Mol Cell Biol; 2014 Mar; 34(6):926-38. PubMed ID: 24379443
[TBL] [Abstract][Full Text] [Related]
11. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
Karvonen U; Jääskeläinen T; Rytinki M; Kaikkonen S; Palvimo JJ
J Mol Biol; 2008 Oct; 382(3):585-600. PubMed ID: 18656483
[TBL] [Abstract][Full Text] [Related]
12. PIASy-mediated repression of the Ets-1 is independent of its sumoylation.
Nishida T; Terashima M; Fukami K
Biochem Biophys Res Commun; 2006 Jul; 345(4):1536-46. PubMed ID: 16729975
[TBL] [Abstract][Full Text] [Related]
13. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
[TBL] [Abstract][Full Text] [Related]
14. PIASy is a SUMOylation-independent negative regulator of the insulin transactivator MafA.
Onishi S; Kataoka K
J Mol Endocrinol; 2019 Nov; 63(4):297-308. PubMed ID: 31614335
[TBL] [Abstract][Full Text] [Related]
15. Protein inhibitors of activated STAT (Pias1 and Piasy) differentially regulate pituitary homeobox 2 (PITX2) transcriptional activity.
Wang J; Sun Z; Zhang Z; Saadi I; Wang J; Li X; Gao S; Engle JJ; Kuburas A; Fu X; Yu W; Klein WH; Russo AF; Amendt BA
J Biol Chem; 2013 May; 288(18):12580-95. PubMed ID: 23515314
[TBL] [Abstract][Full Text] [Related]
16. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
[TBL] [Abstract][Full Text] [Related]
17. Rod/Zw10 complex is required for PIASy-dependent centromeric SUMOylation.
Ryu H; Azuma Y
J Biol Chem; 2010 Oct; 285(42):32576-85. PubMed ID: 20696768
[TBL] [Abstract][Full Text] [Related]
18. Distinct functional modes of SUMOylation for retinoid X receptor alpha.
Lee WP; Jena S; Rodriguez EP; O'Donovan SP; Wagner C; Jurutka PW; Thompson PD
Biochem Biophys Res Commun; 2015 Aug; 464(1):195-200. PubMed ID: 26116533
[TBL] [Abstract][Full Text] [Related]
19. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis.
Bischof O; Schwamborn K; Martin N; Werner A; Sustmann C; Grosschedl R; Dejean A
Mol Cell; 2006 Jun; 22(6):783-794. PubMed ID: 16793547
[TBL] [Abstract][Full Text] [Related]
20. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
Lee PS; Chang C; Liu D; Derynck R
J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
